PODCAST · health
Medical Digest & Congress Report
by Medical Congress News
The MedicalDigest.org / CongressReport.eu podcast covers the latest evidence based medical news from cardiology, hematology, oncology, diabetology, pulmonology, dermatology, urology and more. Made for healthcare professionals and researchers, we are an independent, open-access platform. CongressReport.eu portal enables HCPs to get acquainted with new clinical trial results, medical diagnostic and treatment guidelines. Our non-promotional website collects and stores the relevant scientific information, KOL insights, key lectures, poster presentations in a user-friendly format.
-
686
Highlights and key takeaways from the 2026 EPA Congress
Professor Meryam Schouler-Ocak provides an expert overview of the most impactful discussions, clinical updates, and essential takeaways from the 2026 EPA Congress, exploring the latest advancements and future directions in psychiatric research and practice.Video: https://medicaldigest.org/scientific-contents/interview:highlights-and-key-takeaways-2026-epa-congress
-
685
Efficacy and Safety of Sotatercept in PH-HFpEF: Results From the Phase 2 CADENCE Trial - report from ACC 2026
Professor Mardi Gomberg-Maitland presents the results from the Phase 2 CADENCE trial, investigating the efficacy and safety of Sotatercept in patients with combined post- and pre-capillary pulmonary hypertension associated with heart failure with preserved ejection fraction (HFpEF).Video: https://medicaldigest.org/scientific-contents/interview:efficacy-and-safety-sotatercept-ph-hfpef-results-phase-2-cadence-trial
-
684
Therapeutic Novelties in the New ACC 2026 Acute Pulmonary Embolism Guideline
Professor Geoffrey D. Barnes examines the therapeutic innovations introduced in the new ACC 2026 Acute Pulmonary Embolism Guideline, focusing on updated treatment protocols and novel anticoagulation strategies presented at the ACC 2026 Annual Congress.Video: https://medicaldigest.org/scientific-contents/interview:therapeutic-novelties-new-acc-2026-acute-pulmonary-embolism-guideline
-
683
Human Challenge Models: A New Gold Standard? - Report from WVCDC 2026
Dr. Stephen Thomas examines the evolving role of human challenge models in vaccine development, debating whether they represent a new gold standard for establishing efficacy and safety at the World Vaccine Congress Washington 2026.Video: https://medicaldigest.org/scientific-contents/interview:human-challenge-models-new-gold-standard
-
682
The INSIS Metacohort Vaccine Safety Study: A Paradigm for Clinical and Immune AEFI Profiling - Report from WVCDC 2026
Professor Asimenia Angelidou discusses the INSIS Metacohort Vaccine Safety Study, establishing a new paradigm for profiling clinical and immune adverse events following immunization (AEFI) at the World Vaccine Congress Washington 2026.Video: https://medicaldigest.org/scientific-contents/interview:insis-metacohort-vaccine-safety-study-paradigm-clinical-and-immune-aefi-profiling
-
681
Building a Future of Vaccine Trust Through Transparency and Innovation - Report from WVCDC 2026
Dr. Yurong Fei-Bloom explores the essential strategies for fostering public confidence in immunization by prioritizing transparency and leveraging technological advancements at the World Vaccine Congress Washington 2026.Video: https://medicaldigest.org/scientific-contents/interview:building-future-vaccine-trust-through-transparency-and-innovation
-
680
Prove it's safe: Is this the new vaccine policy "norm?" - Report from WVCDC 2026
Dr. Richard Hughes IV examines the shifting landscape of immunization mandates and public health legislation, questioning whether the heightened demand for safety proof is becoming the new standard for vaccine policy at the World Vaccine Congress Washington 2026.Video: https://medicaldigest.org/scientific-contents/interview:prove-its-safe-new-vaccine-policy-norm
-
679
Combining Respiratory Vaccines - Balancing Efficacy, Durability and Immunization Schedules - Report from WVCDC 2026
Dr. Bill Hausdorff explores the complex dynamics of combining respiratory vaccines, focusing on how to optimize clinical efficacy and long-term durability while streamlining complex immunization schedules at the World Vaccine Congress Washington 2026.Video: https://medicaldigest.org/scientific-contents/interview:combining-respiratory-vaccines-balancing-efficacy-durability-and-immunization-schedules
-
678
Discontinuation of β-blocker Therapy in Stabilized Patients After Acute Myocardial Infarction - report from ACC 2026
Professor Joo-Yong Hahn presents critical insights on the discontinuation of beta-blocker therapy in stabilized patients following an acute myocardial infarction, discussing the clinical implications and trial findings at the ACC 2026 Annual Congress.Video: https://medicaldigest.org/scientific-contents/interview:discontinuation-b-blocker-therapy-stabilized-patients-after-acute-myocardial-infarction
-
677
Meet the Experts: 2025 High Blood Pressure Guideline - report from ACC 2026
Professor Daniel Jones joins a panel of distinguished specialists to provide expert commentary on the 2025 High Blood Pressure Guideline, focusing on evidence-based strategies for clinical implementation at the ACC 2026 Annual Congress.Video: https://medicaldigest.org/scientific-contents/interview:2025-high-blood-pressure-guideline
-
676
2026 Acute Pulmonary Embolism Guideline
Professor Gregory Piazza provides an expert overview of the newly released 2026 Acute Pulmonary Embolism Guideline, focusing on critical updates in diagnosis and management at the ACC 2026 Annual Congress.Video: https://medicaldigest.org/scientific-contents/interview:acute-pulmonary-embolism-guideline-2026
-
675
Meet the Experts: 2025 High Blood Pressure Guideline - report from ACC 2026
Professor Keith C. Ferdinand joins a panel of experts to discuss the practical implementation and clinical implications of the 2025 High Blood Pressure Guideline at the ACC 2026 Annual Congress.Video: https://medicaldigest.org/scientific-contents/interview:meet-experts-2025-high-blood-pressure-guideline
-
674
Kardinal: A Phase 2 Study of Tonlamarsen For the Treatment of Uncontrolled Hypertension - report from ACC 2026
Dr. Luke Laffin presents the results of the Kardinal Phase 2 study, investigating the efficacy of Tonlamarsen as a novel treatment option for patients with uncontrolled hypertension at the ACC 2026 Annual Congress.Video: https://medicaldigest.org/scientific-contents/interview:kardinal-phase-2-study-tonlamarsen-treatment-uncontrolled-hypertension
-
673
Pulmonary Embolism in 2026: A Case-Based Journey From Diagnosis to Recovery - report from ACC 2026
Prof. Stanislav Henkin and Prof. Daniella Kadian-Dodov lead a comprehensive, case-based exploration of pulmonary embolism management in 2026, tracking the patient journey from initial diagnosis through to long-term recovery strategies at the ACC 2026 Annual Congress.Video: https://medicaldigest.org/scientific-contents/interview:pulmonary-embolism-2026-case-based-journey-diagnosis-recovery
-
672
Mavacamten in Symptomatic Adolescent Patients With Obstructive HCM: Results From the Phase 3 Scout-HCM Trial - report from ACC 2026
Professor Joseph William Rossano presents the highly anticipated results from the Phase 3 Scout-HCM trial, evaluating the efficacy and safety of Mavacamten in symptomatic adolescent patients living with obstructive hypertrophic cardiomyopathy at the ACC 2026 Annual Congress.Video: https://medicaldigest.org/scientific-contents/interview:mavacamten-symptomatic-adolescent-patients-obstructive-hcm-results-phase-3-scout-hcm-trial
-
671
Saving Women's Hearts - report from ACC 2026
Professor Roxana Mehran addresses the critical need for gender-specific approaches in cardiovascular care, discussing strategies and clinical advancements aimed at saving women's hearts at the ACC 2026 Annual Congress.Video: https://medicaldigest.org/scientific-contents/interview:saving-womens-hearts
-
670
Highlights of the 2026 ACC/AHA Dyslipidemia Guideline
Professor Carol F. Kirkpatrick highlights the most critical updates and clinical recommendations from the 2026 ACC/AHA Dyslipidemia Guideline, focusing on new management targets and therapeutic strategies for lipid disorders at the ACC 2026 Annual Congress.Video: https://medicaldigest.org/scientific-contents/interview:highlights-2026-accaha-dyslipidemia-guideline
-
669
An Update on Cardiac Prevention Medications: Hypertension and Incretin in Focus - report from ACC 2026
Professor Peter P. Toth provides a comprehensive update on the latest pharmacological strategies in cardiac prevention, specifically focusing on the evolving roles of hypertension management and incretin-based therapies at the ACC 2026 Annual Congress.Video: https://medicaldigest.org/scientific-contents/interview:update-cardiac-prevention-medications-hypertension-and-incretin-focus
-
668
Effects of Tirzepatide vs. Dulaglutide on Cardiorenal Outcomes: SURPASS-CVOT Analysis - report from ACC 2026
Professor Steven E. Nissen presents a critical analysis of the SURPASS-CVOT data, comparing the effects of Tirzepatide and Dulaglutide on expanded cardiorenal outcomes in patients at high cardiovascular risk at the ACC 2026 Annual Congress.Video: https://medicaldigest.org/scientific-contents/interview:effects-tirzepatide-vs-dulaglutide-cardiorenal-outcomes-surpass-cvot-analysis
-
667
Next-Generation Lipid Treatment Options - report from ACC 2026
Professor Robert S. Rosenson explores the evolving landscape of lipid management, detailing next-generation treatment options and their potential to transform cardiovascular risk reduction at the ACC 2026 Annual Congress.Video: https://medicaldigest.org/scientific-contents/interview:next-generation-lipid-treatment-options
-
666
Fine tuning prostate cancer diagnostics - report from EAU 2026
Professor Armando Stabile discusses the latest advancements and precision methods in fine tuning prostate cancer diagnostics at the EAU 2026 Annual Congress.Video: https://medicaldigest.org/scientific-contents/interview:fine-tuning-prostate-cancer-diagnostics
-
665
Prehospital Heparin Administration in Patients With STEMI Undergoing Primary PCI - report from ACC 2026
Prof. Misa Fister and Prof. Tomaz Goslar evaluate the clinical impact and safety of prehospital heparin administration for patients with STEMI undergoing primary PCI, sharing key findings at the ACC 2026 Annual Congress.Video: https://medicaldigest.org/scientific-contents/interview:prehospital-heparin-administration-patients-stemi-undergoing-primary-pci
-
664
Interventional Cardiology Highlights of ACC.26
Professor Roxana Mehran provides an expert review of the most impactful interventional cardiology developments from the ACC 2026 Annual Congress, focusing on new stent technologies, structural heart interventions, and complex PCI outcomes.Video: https://medicaldigest.org/scientific-contents/interview:interventional-cardiology-highlights-acc26
-
663
Efficacy and Safety of Enlicitide Decanoate: Results from the Phase 3 CORALreef AddOn Trial - report from ACC 2026
Professor Alberico L. Catapano presents findings from the Phase 3 CORALreef AddOn trial, evaluating the oral PCSK9 inhibitor enlicitide decanoate versus bempedoic acid and ezetimibe in statin-treated patients with hypercholesterolemia.Video: https://medicaldigest.org/scientific-contents/interview:efficacy-and-safety-enlicitide-decanoate-results-phase-3-coralreef-addon-trial
-
662
Highlights of ACC.26
Professor Christopher Kramer shares the most significant breakthroughs, late-breaking clinical trials, and key takeaways from the ACC 2026 Annual Congress, summarizing the future of cardiovascular care.Video: https://medicaldigest.org/scientific-contents/interview:highlights-acc26
-
661
2026 Acute Pulmonary Embolism Guideline
Professor Mark A. Creager provides an in-depth overview of the newly released 2026 Acute Pulmonary Embolism Guideline, highlighting key updates in clinical management and patient outcomes at the ACC 2026 Annual Congress.Video: https://medicaldigest.org/scientific-contents/interview:2026-acute-pulmonary-embolism-guideline
-
660
Cutting-edge strategies in bladder cancer: Trials, techniques, and predictive tools - report from EAU 2026
Professor Richard P. Meijer explores the frontier of bladder cancer management, focusing on innovative clinical trials, advanced surgical techniques, and the implementation of predictive tools to improve patient outcomes at the EAU 2026 Annual Congress.Video: https://medicaldigest.org/scientific-contents/interview:cutting-edge-strategies-bladder-cancer
-
659
MIBC - There is a gender bias in bladder cancer diagnosis and treatment - Women experience delays, misdiagnosis, worse outcomes - report from EAU 2026
Professor Niyati Lobo addresses the critical issue of gender bias in bladder cancer, highlighting how diagnostic delays and misdiagnoses lead to significantly worse clinical outcomes for women with MIBC at the EAU 2026 Annual Congress.Video: https://medicaldigest.org/scientific-contents/interview:mibc-there-gender-bias-bladder-cancer-diagnosis-and-treatment-women-experience-delays-misdiagnosis-worse-outcomes
-
658
Guidelines Controversies - Paeds and MIBC - report from EAU 2026
Professor Antoine G. van der Heijden explores the most debated topics within the EAU Guidelines, focusing on the latest controversies in pediatric urology and the management of Muscle-Invasive Bladder Cancer (MIBC) at the EAU 2026 Annual Congress.Video: https://medicaldigest.org/scientific-contents/interview:guidelines-controversies-paeds-and-mibc
-
657
Adaptive recurrence risk predictions to optimise prostate cancer follow-up: Results of model validation and clinical impact - report from EAU 2026
Joran Schoorlemmer presents the results of model validation and the clinical impact of adaptive recurrence risk predictions, focusing on how these tools can optimise follow-up strategies for prostate cancer at the EAU 2026 Annual Congress.Video: https://medicaldigest.org/scientific-contents/interview:adaptive-recurrence-risk-predictions-optimise-prostate-cancer-follow-results-model-validation-and-clinical-impact
-
656
The role of urine biomarkers in detection of bladder cancer - report from EAU 2026
Professor Yair Lotan examines the clinical utility and future potential of urine biomarkers, focusing on how they are transforming the early detection and surveillance of bladder cancer at the EAU 2026 Annual Congress.Video: https://medicaldigest.org/scientific-contents/interview:role-urine-biomarkers-detection-bladder-cancer
-
655
Urology trials in bladder and prostate cancer - report from EAU 2026
Professor Ashkan Mortezavi provides a comprehensive overview of the most significant recent and ongoing clinical trials in bladder and prostate cancer, highlighting their impact on future treatment standards at the EAU 2026 Annual Congress.Video: https://medicaldigest.org/scientific-contents/interview:urology-trials-bladder-and-prostate-cancer
-
654
Cutting-edge strategies in bladder cancer: Trials, techniques, and predictive tools - report from EAU 2026
Professor Nikhil Vasdev explores the latest advancements in bladder cancer management, focusing on clinical trials, innovative surgical techniques, and the use of predictive tools at the EAU 2026 Annual Congress.Video: https://medicaldigest.org/scientific-contents/interview:cutting-edge-strategies-bladder-cancer-trials-techniques-and-predictive-tools
-
653
Redefining EMBARK-like Patients in the PSMA Era: Impact of PSMA-PET Restaging on Disease Classification and Management - report from EAU 2026
Professor Alessandro Viti discusses the impact of PSMA-PET restaging on disease classification and management, redefining "EMBARK-like" patients in the modern PSMA era at the EAU 2026 Annual Congress.Video: https://medicaldigest.org/scientific-contents/interview:redefining-embark-patients-psma-era-impact-psma-pet-restaging-disease-classification-and-management
-
652
Progression-free survival following primary staging with [¹⁸F]PSMA-1007 PET/ceCT versus Na[¹⁸F]F-PET/ceCT in prostate cancer: Results from the PRISMA PET randomized controlled trial
Karen Middelbo Buch-Olsen and Mads Hvid Poulsen present the highly anticipated results from the PRISMA PET randomized controlled trial, comparing progression-free survival in prostate cancer staging between [¹⁸F]PSMA-1007 PET/ceCT and Na[¹⁸F]F-PET/ceCT at the EAU 2026 Annual Congress.Video: https://medicaldigest.org/scientific-contents/interview:progression-free-survival-following-primary-staging-fpsma-1007-petcect-versus-naff-petcect-prostate-cancer-results-prisma-pet-randomized-controlled-trial
-
651
2026 EAU Guidelines update and controversies – Urolithiasis, female and male LUTS and infections: What has changed?
Professor Arjun Konath Nambiar provides a critical update on the 2026 EAU Guidelines, exploring the latest changes and ongoing controversies in urolithiasis, male and female LUTS, and urological infections at the EAU 2026 Annual Congress.Video: https://medicaldigest.org/scientific-contents/interview:2026-eau-guidelines-update-and-controversies-urolithiasis-female-and-male-luts-and-infections-what-has-changed
-
650
Infections: Prophylactic antibiotics in renal cancer surgery - Safeguarding patients from postoperative infection - report from EAU 2026
Professor Florian M. E. Wagenlehner discusses the critical role of prophylactic antibiotics in renal cancer surgery and effective strategies for safeguarding patients from postoperative infections at the EAU 2026 Annual Congress.Video: https://medicaldigest.org/scientific-contents/interview:infections-prophylactic-antibiotics-renal-cancer-surgery-safeguarding-patients-postoperative-infection
-
649
Antibiotics & renal health: Striking the perfect balance between benefit and risk - report from EAU 2026
Professor Merel M.C. Lambregts discusses the delicate clinical challenge of antibiotics and renal health, exploring how to strike the perfect balance between therapeutic benefit and potential risk at the EAU 2026 Annual Congress.Video: https://medicaldigest.org/scientific-contents/interview:antibiotics-renal-health-striking-perfect-balance-between-benefit-and-risk
-
648
Navigating the future of urologic care - report from EAU 2026
Professor Andreas Røder discusses the evolving landscape and strategic shifts navigating the future of urologic care at the EAU 2026 Annual Congress.Video: https://medicaldigest.org/scientific-contents/interview:navigating-future-urologic-care
-
647
From MRI to Post-treatment care: prostate cancer screening - report from EAU 2026
Professor Hendrik Van Poppel discusses the complete pathway of prostate cancer screening, from the initial role of MRI to the nuances of post-treatment care at the EAU 2026 Annual Congress.Video: https://medicaldigest.org/scientific-contents/interview:mri-post-treatment-care-prostate-cancer-screening
-
646
Prostate cancer: PARPIs finally explained - report from EAU 2026
Professor Alexander W. Wyatt breaks down the complexities of PARP inhibitors (PARPIs), providing a clear and comprehensive explanation of their role in treating prostate cancer at the EAU 2026 Annual Congress.Video: https://medicaldigest.org/scientific-contents/interview:prostate-cancer-parpis-finally-explained
-
645
Retroperitoneal lymph dissection considerations in testicular cancer - report from EAU 2026
Professor Anna Thor discusses the critical clinical considerations and surgical nuances of retroperitoneal lymph node dissection in the management of testicular cancer at the EAU 2026 Annual Congress.Video: https://medicaldigest.org/scientific-contents/interview:retroperitoneal-lymph-dissection-considerations-testicular-cancer
-
644
How imaging is shaping prostate cancer management: Screening and early detection - report from EAU 2026
Professor Laurence H. Klotz discusses the promising trends in screening and early detection, highlighting how imaging is shaping the future of prostate cancer management at the EAU 2026 Annual Congress.Video: https://medicaldigest.org/scientific-contents/interview:how-imaging-shaping-prostate-cancer-management-screening-and-early-detection
-
643
Advancing BPO treatment: From aquablation to enucleation - report from EAU 2026
Professor Bogdan Florin Geavlete explores the evolution of BPO treatment, covering advancements from aquablation to enucleation techniques at the EAU 2026 Annual Congress.Video: https://medicaldigest.org/scientific-contents/interview:advancing-bpo-treatment-aquablation-enucleation
-
642
Kidney stones made simple: Best clinical practice and preventing complications - report from EAU 2026
Professor Begoña Ballesta Martínez provides a comprehensive update for all urologists, focusing on best clinical practices and strategies for preventing complications in kidney stone management at EAU 2026.Video: https://medicaldigest.org/scientific-contents/interview:kidney-stones-made-simple-best-clinical-practice-and-preventing-complications
-
641
Kidney stones made simple: A comprehensive update for all urologists - report from EAU 2026
Professor Mariela Corrales Acosta provides a comprehensive update on kidney stone management, simplifying complex clinical challenges for all urologists at the EAU 2026 Annual Congress.Video: https://medicaldigest.org/scientific-contents/interview:kidney-stones-made-simple-comprehensive-update-all-urologists
-
640
Navigating the future of urologic care: Trials in progress - report from EAU 2026
Professor Tyler M. Seibert discusses the upcoming breakthroughs and ongoing clinical trials navigating the future of urologic care at the EAU 2026 Annual Congress.Video: https://medicaldigest.org/scientific-contents/interview:navigating-future-urologic-care-trials-progress
-
639
How imaging is shaping prostate cancer management - report from EAU 2026
Professor Giovanni Lughezzani discusses the transformative role of imaging in shaping the management of prostate cancer at the EAU 2026 Annual Congress.Video: https://medicaldigest.org/scientific-contents/interview:how-imaging-shaping-prostate-cancer-management
-
638
Increasing role of triple therapy in COPD - report from IWLH 2026
Professor Fabiano Di Marco ediscusses the increasing role of triple therapy in COPD at the 13th International Workshop On Lung Health.Video: https://medicaldigest.org/scientific-contents/interview:increasing-role-triple-therapy-copd
-
637
Redefining epithelial driven airway inflammation: insights from clinical experience with Tezepelumab - report from IWLH 2026
Professor Corrado Pelaia explains his insights from clinical experience with Tezepelumab at the 13th International Workshop On Lung Health.Video: https://medicaldigest.org/scientific-contents/interview:redefining-epithelial-driven-airway-inflammation-insights-clinical-experience-tezepelumab
No matches for "" in this podcast's transcripts.
No topics indexed yet for this podcast.
Loading reviews...
ABOUT THIS SHOW
The MedicalDigest.org / CongressReport.eu podcast covers the latest evidence based medical news from cardiology, hematology, oncology, diabetology, pulmonology, dermatology, urology and more. Made for healthcare professionals and researchers, we are an independent, open-access platform. CongressReport.eu portal enables HCPs to get acquainted with new clinical trial results, medical diagnostic and treatment guidelines. Our non-promotional website collects and stores the relevant scientific information, KOL insights, key lectures, poster presentations in a user-friendly format.
HOSTED BY
Medical Congress News
Loading similar podcasts...